PFKFB4 promotes endometrial cancer by regulating glycolysis through SRC‑3 phosphorylation
Oncology Reports · 2025
DOI: 10.3892/or.2025.8886 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Reports, 2025. Verfasst von Yaling Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Phosphofructokinase-2, Nuclear Receptor Coactivator 3. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China.
- Department of Gynecology and Obstetrics, People's Hospital of Shanxi, Taiyuan, Shanxi 030012, P.R. China.
- Department of Pathology, People's Hospital of Shanxi, Taiyuan, Shanxi 030012, P.R. China.
Zitieren
APA
Wu, Y., Zhao, J., Zhao, S., Li, J., Luo, J., & Wang, Y. (2025). PFKFB4 promotes endometrial cancer by regulating glycolysis through SRC‑3 phosphorylation. Oncology Reports. https://doi.org/10.3892/or.2025.8886
Vancouver
Wu Y, Zhao J, Zhao S, Li J, Luo J, Wang Y. PFKFB4 promotes endometrial cancer by regulating glycolysis through SRC‑3 phosphorylation. Oncology Reports. 2025. doi:10.3892/or.2025.8886
BibTeX
@article{Wu2025,
author = {Wu, Yaling and Zhao, Jianzhen and Zhao, Shuangshuang and Li, Jianfang and Luo, Jin and Wang, Yingmei},
title = {PFKFB4 promotes endometrial cancer by regulating glycolysis through SRC‑3 phosphorylation},
journal = {Oncology Reports},
year = {2025},
doi = {10.3892/or.2025.8886}
}
EUVIMED